Please login to the form below

Not currently logged in
Email:
Password:

New Merck Foundation appoints Rasha Kelej

She takes up role as CEO of the pharma firm's newly-established non-profit

Rasha KelejRasha Kelej has been appointed chief executive officer for Merck KGaA’s non-profit limited liability company, The Merck Foundation.

Prior to her new position at The Merck Foundation, Kelej has held numerous roles at Merck, including vice president, head of global business for Merck Serono, chief social officer for Merck Group, and subsequently as its senior vice president.

She said: “The Merck Foundation will focus on initiatives that will contribute towards the Sustainable Development Goals outlined by the United Nations.

“To achieve the foundation’s goals, we will develop and implement coherent strategies, result-oriented programs and initiatives, provide grants to support projects and help raise funds where needed.”

Chairman of the board of trustees for The Merck Foundation, Frank Stangenberg-Haverkamp, added: “The vision of the new foundation is a world where everyone can lead a healthy and fulfilling life, also those living under disadvantaged conditions.

“With The Merck Foundation we will continue our commitment towards improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and advancing people’s lives through science and technology.”

The Foundation will be chaired by Stangenberg-Haverkamp and he will advise and monitor its performance.

28th June 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics